| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/23/2009 | WO2009153960A1 Glycosylated glp-1 peptide |
| 12/23/2009 | WO2009153923A1 Process for producing soluble feather keratin protein |
| 12/23/2009 | WO2009153801A1 Dna vaccine based on glycoprotein gene of rabies virus conjugated to lamp-1 signal sequence at the c-terminus and an adjuvant; and method of its preparation thereof |
| 12/23/2009 | WO2009153518A2 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 12/23/2009 | WO2009153463A1 Immunogenic peptides derived from the midkine protein, as an anticancer vaccine |
| 12/23/2009 | WO2009153418A1 Harp peptides inhibiting tumour growth |
| 12/23/2009 | WO2009153414A1 Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 12/23/2009 | WO2009153337A1 Infection inhibitor |
| 12/23/2009 | WO2009153208A1 Plants having enhanced yield-related traits and a method for making the same |
| 12/23/2009 | WO2009153046A1 Marker of streptococcus anginosus / streptococcus constellatus (moac) and uses thereof |
| 12/23/2009 | WO2009152986A1 Muc16 fragments with antigenic activity and pharmaceutical compositions thereof |
| 12/23/2009 | WO2009152969A1 Recombinant modified vaccinia virus measles vaccine |
| 12/23/2009 | WO2009152944A1 Modified erythropoietin (epo)polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof |
| 12/23/2009 | WO2009152901A1 Methods for treatment of malignancies |
| 12/23/2009 | WO2009152621A1 Novel canola protein isolate |
| 12/23/2009 | WO2009152620A1 Novel canola protein isolate |
| 12/23/2009 | WO2009152610A1 Interleukin-2/soluble tgf-beta type ii receptor b conjugates and methods and uses thereof |
| 12/23/2009 | WO2009135056A3 Recombinant dna vectors for expression of human prolactin antagonists |
| 12/23/2009 | WO2009125424A3 Peptidomimetics with glucagon antagonistic and glp-1 agonistic activities |
| 12/23/2009 | WO2009120831A3 Novel n-and c-terminal substituted -antagonistic analogs of human gh-rh |
| 12/23/2009 | WO2009116894A3 Oxygen-transferring blood substitute and a pharmaceutical composition (variants) |
| 12/23/2009 | WO2009111781A3 Chimeric c3-like rho antagonist bone therapeutic |
| 12/23/2009 | WO2009105585A3 Postsynaptically targeted chemodenervation agents and their methods of use |
| 12/23/2009 | WO2009100035A3 Interleukin-21 (il-21) and il-21 receptor (il-21r) modulation of regulatory t cells and forkhead box p3 (foxp3) |
| 12/23/2009 | WO2009083958A3 Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants |
| 12/23/2009 | WO2009079566A3 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production |
| 12/23/2009 | WO2009036092A3 Mitochondria-targeted anti-tumour agents |
| 12/23/2009 | WO2009019612A3 Lentiviral gene transfer vectors and their medicinal applications |
| 12/23/2009 | WO2008112325A3 Treatment of autoimmune disorders |
| 12/23/2009 | WO2001000790A9 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 12/23/2009 | WO2000015247A8 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 12/23/2009 | EP2135953A1 Novel hemopoietin receptor protein, Nr. 10 |
| 12/23/2009 | EP2135952A2 Cripto antagonism of activin and TGF-beta signaling |
| 12/23/2009 | EP2135951A1 Transgenic rodents having ngf beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins |
| 12/23/2009 | EP2135878A1 Tumor-associated peptide binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 12/23/2009 | EP2135877A1 Marker of steptococcus anginosus/Streptococcus constellatus (Moac) and uses thereof |
| 12/23/2009 | EP2135876A2 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy |
| 12/23/2009 | EP2134843A1 Kunitz-type recombinant inhibitor |
| 12/23/2009 | EP2134745A1 Human fc gamma receptor iii |
| 12/23/2009 | EP2134744A2 Schizophrenia-related isoform of kcnh2 and development of antipsychotic drugs |
| 12/23/2009 | EP2134743A2 Improved vaccines against bordetella pertussis based on lps glycosyltransferase mutants |
| 12/23/2009 | EP2134740A2 Self-assembling nanoparticle drug delivery system |
| 12/23/2009 | EP2134165A2 Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone |
| 12/23/2009 | EP1743040B1 Hdm2-inhibitor complexes and uses thereof |
| 12/23/2009 | EP1687329B1 Optimized expression of hpv 58 l1 in yeast |
| 12/23/2009 | EP1575979B1 West nile virus vaccine |
| 12/23/2009 | EP1425295B1 Modified peptides and their use for the treatment of autoimmune diseases |
| 12/23/2009 | EP1421174B1 Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 12/23/2009 | EP1397499B1 Aav helper plasmids for helper virus-free packaging and pseudo typification of aav vectors |
| 12/23/2009 | EP1385946B1 A system for inducible expression in eukaryotic cells |
| 12/23/2009 | EP1341808B1 Synthetic nucleic acid molecule compositions and methods of preparation |
| 12/23/2009 | EP1312259B1 Type iii allergic inflammation model animal |
| 12/23/2009 | EP1290028B1 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
| 12/23/2009 | EP1274726B1 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 12/23/2009 | EP1104471B1 Pesticidal toxins and genes from bacillus laterosporus strains |
| 12/23/2009 | EP1094837B1 Porcine circovirus and parvovirus vaccine |
| 12/23/2009 | CN101611320A Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the diagnosis of inflammatory intestinal diseases and chronic pan |
| 12/23/2009 | CN101611318A Biomarkers |
| 12/23/2009 | CN101611144A Recombinant viral proteins and particles |
| 12/23/2009 | CN101611056A Peptides capable of binding to serum proteins |
| 12/23/2009 | CN101611053A Anti-angiogenic compounds |
| 12/23/2009 | CN101611052A Multimeric FC receptor polypeptides including a modified FC domain |
| 12/23/2009 | CN101611051A Pharmaceutical compositions for treating or preventing bone conditions |
| 12/23/2009 | CN101610786A Prevention and treatment of sub-clinical PCVD |
| 12/23/2009 | CN101610785A 多价肺炎球菌多糖-蛋白质缀合物组合物 Multivalent pneumococcal polysaccharide - protein conjugate composition |
| 12/23/2009 | CN101610782A Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity |
| 12/23/2009 | CN101608206A Method for preparing soy protein immune-active peptides and product thereof |
| 12/23/2009 | CN101608203A Fish skin collagen peptide with moistening effect and preparation process and application thereof |
| 12/23/2009 | CN101608201A Method for producing novel streptococcus thermophilus bacteriocin |
| 12/23/2009 | CN101608186A Method for preparing transgenic goat with high expression of human lactoferrin by somatic cell transfection |
| 12/23/2009 | CN101608182A Oncogene, recombinant protein derived therefrom, and uses thereof |
| 12/23/2009 | CN101607993A Extraction process for collagen of channel catfish skin |
| 12/23/2009 | CN101607992A Antibacterial peptide separated from cow blood and code sequence and application thereof |
| 12/23/2009 | CN101607991A Method for preparing venom edema factor inhibition protein and application thereof |
| 12/23/2009 | CN101607990A Earthworm active protein, extraction method and application thereof |
| 12/23/2009 | CN101607989A Rice dwarf-related protein and coding gene and application thereof |
| 12/23/2009 | CN101607988A Technique for extracting phycocyanin, chlorophyll and spirulina polysaccharide in spirulina |
| 12/23/2009 | CN101607987A Lactobacillin plantarum and preparation method |
| 12/23/2009 | CN101607984A Multi-copy polypeptide and application thereof |
| 12/23/2009 | CN101607913A 改进的螯合剂缀合物 Improved chelator conjugate |
| 12/23/2009 | CN100572538C Gene adjusting and controlling rice tillering angle and its coded protein and use |
| 12/23/2009 | CN100572535C Specifically expressed gene in dopamine-producing neuron precursor cells after termination of division |
| 12/23/2009 | CN100572534C Process for producing physiologically active protein using genetically modified silkworm |
| 12/23/2009 | CN100572394C Comprehensive extraction process of active components in fresh pilose antler |
| 12/23/2009 | CN100572393C Dog interferon alpha preparation process and use thereof |
| 12/23/2009 | CN100572392C 截短tau蛋白 Truncated tau protein |
| 12/23/2009 | CN100572391C Beta-fodrin antigen epitope polypeptide, and its screening method and use |
| 12/23/2009 | CN100572389C BIM apoptosis effect minimum core sequence and its preparation and uses |
| 12/23/2009 | CA2852177A1 Glucagon/glp-1 receptor co-agonists |
| 12/23/2009 | CA2728459A1 Immunogenic peptides derived from the midkine protein, as an anticancer vaccine |
| 12/23/2009 | CA2728308A1 Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains |
| 12/23/2009 | CA2728284A1 Glucagon/glp-1 receptor co-agonists |
| 12/23/2009 | CA2728276A1 Combination therapies against cancer |
| 12/23/2009 | CA2728258A1 Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains |
| 12/23/2009 | CA2728233A1 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 12/23/2009 | CA2728120A1 Pigf-1 assay and kits and components thereof |
| 12/23/2009 | CA2728060A1 Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 12/23/2009 | CA2727465A1 Improved peptide mediators of cholesterol efflux |
| 12/23/2009 | CA2727147A1 Glycosylated glp-1 peptide |
| 12/23/2009 | CA2727048A1 Novel canola protein isolate |